Prognostic value of the expression of adhesion molecules for non-clear-cell variants of renal cell carcinoma

Arkhiv Patologii

Volumn 75, Issue 4, 2013, Pages 3-8

  Moskvina, L V ^a   Andreeva, Yu Yu ^a,b   Frank, G A ^a,b   Zavaushina, L E ^a,b   Petrov, A N ^a   Malkov, P G ^b,c  

^a P A Herzen Research Oncological Institute   (Russian Federation)

^b Russian Medical Academy of Postgraduate Education   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Immunohistochemistry; Non clear cell renal cell carcinoma; Prognosis

Indexed keywords

CELL ADHESION MOLECULE; TUMOR PROTEIN;

ARTICLE; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY;

CARCINOMA, RENAL CELL; CELL ADHESION MOLECULES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES;

EID: 84885929785     PISSN: 00041955     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Eble J.N., Sauter G, Epstein J. I., Sesterhenn LA. Tumors of the system and male genital organs. Lyon, France: IARC Press; 2004.
2. Iczkowski K.A. Cell adhesion molecule CD44: its functional roles in prostate cancer. Am. J. Transl. Res. 2010; 3 (1): 1-7.
3. Kan M., Aki M., Akiyama K., Naruo S., Kanayama H., Kagawa S. High-level expression of the CD44 variant sharing exon vlO in renal cancer. Jpn. J. Cancer Res. 1995; 86 (9): 847-53.
4. Terpe H.J., Storkel S., Zimmer U., Anquez V., Fischer C, Pantel K., Gunthert U. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am. J. Pathol. 1996; 148 (2): 453-63.
5. Paradis V., Ferlicot S., Ghannam E., Zeimoura L., Blanchet P., Eschwege P. et al. CD44 is an independent prognostic factor in conventional renal cell carcinomas. J. Urol. 1999; 161 (6): 1984-7.
6. de Alava E., Panizo A., Sola I., Rodriguez-Rubio EL, Pardo-Minddn F.J. CD44v6 expression is related to progression in renal epithelial tumours. Histopathology. 1998; 33 (1): 39-45.
7. Kroeze S.G., Bijenhoj A.M., Bosch J.L., Jans J.J. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma. Cancer Biomark. 2010; 7 (6): 261-8.
8. Yildiz E., Gokce G., Kilicarslan H., Ayan S., Goze O.F., Gultekin E. Y. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. Br. J. Urol. Int. 2004; 93 (7): 1087-93.
9. Ljungberg B., Cowan N., Hanbury D.C., Hara M., Kuczyk M.A., Merseburger A.S. et al. pak. 2011. http:// www.uroweb.org/gls/pdf/russian/4-Renall-Cell- Carcinoma.pdf
10. Li Y., Kuwahara H., Ren J. et al. The c-Src tyrosinase kinase regulates signalling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J. Biol. Chem. 2001; 276: 6061-4.
11. Langner C, Ratschek M., Rehak P., Schips L., Zigeuner R. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases. Mod. Pathol. 2004; 17 (2): 180-8.
12. Bamias A., Chorti M., Deliveliotis C. et al. Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma. Urology. 2003; 62: 368-73.
13. Denda-Nagai K, Fujita K, Fujime M. et al. Absence of correlation of M UC1 expression to malignant behavior of renal cell carcinoma in experimental systems. Clin. Exp. Metast. 2000; 18: 77-81.
14. Aubert S., Fauquette V., Hémon B., Lepoivre R., Briez N., Bernard D. et al. M UC 1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression. Cancer Res. 2009; 69 (14): 5707-15. doi: 10.1158/0008-5472.CAN-08-4905.
15. Shen S.S., Truong L.D., Scarpelli M., Lopez-Beltran A. Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? Arch. Pathol. Lab. Med. 2012; 136 (4): 410-7.